≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Magnesium deficiency

EFO Endpoint Browser PheWeb

E4_MG_DEF

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — E61.2#
  • Cause of death: ICD-10 — E61.2#

2 out of 7 registries used, show all original rules.

98

4. Check minimum number of events

None

98

5. Include endpoints

None

98

6. Filter based on genotype QC (FinnGen only)

98

Control definitions (FinnGen only)

Control exclude
E4_NUTRIDEF

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
E61
Name in latin
Deficientia magnesii

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 425 193 228
Only index persons 408 188 220
Unadjusted period prevalence (%)
Whole population 0.01 0.01 0.01
Only index persons 0.01 0.01 0.01
Median age at first event (years)
Whole population 65.03 66.98 63.78
Only index persons 65.36 67.07 63.90

-FinnGen-

Key figures

All Female Male
Number of individuals 98 48 50
Unadjusted period prevalence (%) 0.02 0.02 0.02
Median age at first event (years) 66.32 67.47 65.22

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
86
Matched controls
860
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
E61.2
ICD-10 Finland
Magnesium deficiency
+∞
123.8
86
*
E87.6
ICD-10 Finland
Hypokalaemia
42.7
22.2
27
9
E83.51
ICD-10 Finland
Hypocalcemia
240.3
19.4
19
*
N02AA05
ATC
oxycodone; systemic
8.8
14.5
34
59
A03FA01
ATC
metoclopramide; systemic, rectal
6.9
14.3
43
108
A49.9
ICD-10 Finland
Bacterial infection, unspecified
9.2
14.2
32
52
TPH04
NOMESCO Finland
Cathetrisation of vein
6.8
14.0
43
110
E83.4
ICD-10 Finland
Disorders of magnesium metabolism
+∞
13.9
13
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
7.5
13.8
37
78
R4190
NOMESCO Finland
Nutritional therapy
18.9
11.4
17
11
WW500
NOMESCO Finland
Blood transfusion
18.9
11.4
17
11
E55.9
ICD-10 Finland
Vitamin D deficiency, unspecified
+∞
10.6
10
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
14.8
10.4
17
14
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
10.1
10.1
20
25
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
17.8
9.9
15
10
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
9.7
9.8
20
26
C03CA01
ATC
furosemide; systemic
4.8
9.6
39
127
130
Kela drug reimbursment
Malignant tumour
8.1
9.6
22
35
H02AB02
ATC
dexamethasone; systemic
6.2
9.2
26
56
ZX120
NOMESCO Finland
Intravenous
7.2
8.9
22
39
J18.9
ICD-10 Finland
Pneumonia, unspecified
4.9
8.9
33
97
R53
ICD-10 Finland
Malaise and fatigue
4.9
8.7
32
93
E53.8
ICD-10 Finland
Deficiency of other specified B group vitamins
99.4
8.6
9
*
C03DA01
ATC
spironolactone; oral
6.3
8.4
23
47
R11
ICD-10 Finland
Nausea and vomiting
9.3
8.4
17
22
D64.9
ICD-10 Finland
Anaemia, unspecified
6.8
8.2
21
39
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
15.0
8.2
13
10
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
12.6
8.1
14
13
A02BC02
ATC
pantoprazole; systemic
4.4
7.9
71
444
AA1AD
NOMESCO Finland
CT of head and brain
4.1
7.9
36
128
R56.8
ICD-10 Finland
Other and unspecified convulsions
9.1
7.8
16
21
TPH07
NOMESCO Finland
Cathetrisation of artery
5.4
7.7
24
57
WX892
NOMESCO Finland
Monitored bed care
6.4
7.5
20
39
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
6.2
7.4
20
40
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
11.5
7.3
13
13
WF004
NOMESCO Finland
Palliative radiotherapy
33.1
7.3
9
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
3.7
7.3
40
163
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
3.6
7.2
44
193
XF600
NOMESCO Finland
Bloodpressure measurement
7.6
7.0
16
25
A01
ICPC
Pain general/multiple sites
7.6
7.0
16
25
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
5.4
7.0
21
48
K92.1
ICD-10 Finland
Melaena
9.1
6.9
14
18
JDB10
NOMESCO Finland
Percutaneous gastrostomy
18.6
6.9
10
6
Z51.5
ICD-10 Finland
Palliative care
8.0
6.9
15
22
215
Kela drug reimbursment
Diabetes, non-insulin-treated
3.7
6.9
35
133
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.4
6.7
54
287
UJF32
NOMESCO Finland
Coloscopy
3.6
6.6
35
137
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
3.8
6.6
31
111
J01MA12
ATC
levofloxacin; systemic
4.0
6.5
28
92
E86
ICD-10 Finland
Volume depletion
75.2
6.5
7
*
WX408
NOMESCO Finland
General anesthesy, balanced
3.4
6.4
41
183
J01MA02
ATC
ciprofloxacin; systemic
3.2
6.4
47
234
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
29.0
6.3
8
*
103
Kela drug reimbursment
Diabetes, insulin-treated
3.5
6.2
35
141
JN3AD
NOMESCO Finland
Abdominal CT examination
6.8
6.2
15
26
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
4.2
6.1
24
73

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3003458) Phosphate [Moles/volume] in Serum or Plasma
67
100
19.02
50.31
9.0
7.2
mmol/l
1.0
1.0
0.59
67
94
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
43
50
14.54
37.05
2.3
1.6
—
—
—
0
0
(3000991) Gas panel - Venous blood
42
64
10.73
29.07
9.0
8.9
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
42
64
10.73
29.07
5.7
4.9
mmol/l
2.6
2.2
0.17
37
48
(3023368) Bacteria identified in Blood by Culture
74
230
10.05
26.46
8.5
4.6
—
—
—
0
0
(3012544) pH of Venous blood
41
68
9.65
26.23
5.3
4.8
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
93
419
24.85
25.24
20.6
7.6
mmol/l
1.2
1.2
2.81
79
360
(3036481) Cortisol [Moles/volume] in Serum or Plasma
45
88
8.61
24.79
4.8
2.4
nmol/l
403.2
382.9
0.26
40
83
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
39
66
9.15
24.36
4.2
4.3
ng/l
103.1
91.4
0.21
31
58
(3018418) pH of Serum or Plasma
76
267
9.23
23.17
13.3
4.3
ph
7.4
7.4
0.20
13
42
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
32
45
10.07
23.16
5.6
5.7
mmol/l
25.0
25.5
0.28
32
45
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
61
180
7.33
22.01
3.2
1.8
mg/l
3.0
3.4
0.39
54
158
(3024561) Albumin [Mass/volume] in Serum or Plasma
87
363
13.44
21.93
13.1
4.7
g/l
31.9
35.2
4.73
87
344
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
20
15
16.50
21.75
1.6
1.3
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
37
82
6.64
17.41
5.6
2.1
u/l
28.2
28.7
0.04
37
72
(3013650) Neutrophils [#/volume] in Blood by Automated count
91
498
12.56
17.04
24.3
11.3
e9/l
4.4
4.1
0.52
78
435
(42870588) Differential panel, method unspecified - Blood
67
267
5.77
15.91
10.1
5.8
—
—
—
0
0
(3026782) Osmolality of Urine
49
163
5.01
14.18
5.1
2.4
mosm/kgh2o
534.9
551.9
0.20
41
137
(3001604) Monocytes [#/volume] in Blood
83
421
7.35
14.17
10.3
5.8
e9/l
0.7
0.6
1.64
69
364
(3006315) Basophils [#/volume] in Blood
83
422
7.32
14.10
10.3
5.8
e9/l
0.0
0.0
0.07
69
365
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
68
294
5.29
14.07
6.3
3.0
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
84
433
7.58
14.00
10.3
5.8
e9/l
1.7
1.8
0.66
72
379
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
48
159
4.96
13.92
10.3
3.3
mmol/l
2.5
2.5
0.16
43
137
(3024928) Oxygen saturation in Venous blood
16
17
11.05
13.82
1.3
3.4
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
60
239
4.90
13.69
5.4
2.9
e6/l
0.8
0.4
0.55
45
171
(3013115) Eosinophils [#/volume] in Blood
84
438
7.42
13.67
10.6
6.2
e9/l
0.2
0.2
0.19
71
386
(3026008) Bacteria identified in Urine by Culture
61
247
4.89
13.60
6.2
2.9
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
63
262
4.93
13.56
6.4
2.9
e6/l
52.1
56.0
0.04
48
195
(36304419) Bacteria [Presence] in Urine
58
229
4.76
13.29
5.4
2.7
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
65
280
4.92
13.28
4.4
2.3
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
22
38
7.18
12.91
3.0
2.6
%
1.5
1.2
0.34
22
38
(3017143) Hepatitis C virus Ab [Presence] in Serum
32
80
5.45
12.87
1.3
1.8
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
32
83
5.24
12.29
1.8
1.8
%
1.8
1.7
0.07
22
74
(3014007) Fractional oxyhemoglobin in Arterial blood
27
61
5.73
12.09
10.8
8.1
%
94.4
93.8
0.25
27
61
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
53
207
4.40
12.06
3.9
2.3
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
36
107
4.74
11.68
9.3
7.7
mmol/l
-0.5
1.4
1.29
30
86
(3018095) Leukocytes [#/volume] in Urine
64
296
4.35
11.32
8.6
3.5
e6/l
118.7
50.7
0.82
48
202
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
77
410
5.10
11.16
6.9
4.1
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
21
42
6.09
10.60
1.6
1.5
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
41
146
4.11
10.31
4.6
2.8
e6/l
0.9
1.0
0.11
24
75
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
40
140
4.14
10.31
6.3
2.9
e6/l
3.8
2.3
0.40
24
69
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
65
319
4.08
10.23
3.4
1.9
pmol/l
80.7
99.1
1.45
43
140
(3032080) INR in Blood by Coagulation assay
67
337
4.12
10.14
11.7
6.7
inr
1.2
1.2
0.02
20
97
(3023520) Reticulocytes [#/volume] in Blood
26
66
5.00
10.09
2.3
4.2
e9/l
69.4
72.9
0.18
20
50
(40758558) Short blood count panel - Blood
51
214
3.88
10.09
19.0
8.0
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
45
174
3.93
10.02
3.8
2.2
e6/l
3.9
4.4
0.23
38
151
(3019309) Folate [Moles/volume] in Red Blood Cells
41
150
3.98
9.86
2.3
1.5
nmol/l
1081.4
1205.9
0.42
31
110
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
25
63
4.98
9.76
11.5
7.8
%
0.7
0.7
0.14
25
63
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
53
237
3.69
9.37
3.7
3.0
ng/l
2902.1
1164.6
1.36
44
196
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
15
24
7.20
9.29
3.7
2.0
u/ml
0.4
0.4
—
10
12
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
27
76
4.52
9.18
7.7
3.5
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
11
12
10.20
9.15
1.0
1.1
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
31
99
4.12
8.91
2.8
1.6
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
29
90
4.16
8.65
1.3
1.7
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
11
13
9.40
8.63
2.8
1.5
%
14.3
16.7
—
6
6
(3025941) Bacteria identified in Stool by Culture
19
42
5.37
8.55
1.6
1.3
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
31
104
3.90
8.27
2.8
1.7
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
10
11
10.01
8.23
2.7
2.7
%
54.8
56.8
—
10
11
(3007853) Bacteria identified in Skin by Aerobe culture
31
105
3.86
8.14
2.0
1.6
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
22
58
4.60
8.05
3.4
2.1
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
39
156
3.49
7.97
10.7
3.3
ng/l
84.4
106.8
0.18
34
130
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
23
64
4.39
7.86
12.3
7.8
%
1.2
1.7
0.94
23
64
(3013290) Carbon dioxide [Partial pressure] in Blood
10
12
9.17
7.72
4.2
1.4
kpa
4.8
5.3
—
10
12
(3027315) Oxygen [Partial pressure] in Blood
10
12
9.17
7.72
4.2
1.4
kpa
8.1
8.5
—
10
12
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
11
15
8.13
7.72
2.0
1.6
—
—
—
0
0
(1616796) Gas panel - Central venous blood
12
9
14.97
7.61
3.7
2.1
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
12
9
14.97
7.61
1.4
1.7
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
35
134
3.51
7.61
3.1
1.8
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
66
371
3.39
7.57
21.0
10.1
e9/l
0.0
0.0
0.48
52
298
(3037467) Urinalysis macro (dipstick) panel - Urine
84
551
4.67
7.54
9.1
4.0
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
33
124
3.50
7.36
3.3
1.9
—
—
—
0
0
(4035726)
25
83
3.70
6.66
1.8
1.3
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
16
39
4.71
6.37
6.5
4.2
mmol/l
1.7
1.5
0.04
11
33
(3009508) Creatinine [Moles/volume] in Urine
47
236
2.91
6.25
3.5
3.1
mmol/l
6.2
7.7
1.96
40
192
(3037522) Nuclear Ab [Titer] in Serum
27
99
3.38
6.15
2.1
1.3
titre
640.0
462.6
—
10
23
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
10
16
6.85
6.08
2.0
1.1
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
10
16
6.85
6.08
2.0
1.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
11
20
6.07
5.95
2.1
1.3
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
12
24
5.56
5.91
1.5
1.5
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
87
637
4.26
5.51
7.8
3.9
mm/h
23.7
12.0
4.63
82
579
(3015736) pH of Urine
54
308
2.68
5.41
3.8
3.7
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
30
126
2.99
5.40
1.7
1.2
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
57
335
2.68
5.36
2.8
2.0
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
16
45
4.05
5.30
2.5
1.7
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
13
31
4.68
5.27
3.9
3.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
10
19
5.75
5.16
1.1
1.2
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
9
9
10.86
5.14
1.8
2.0
ug/l
14.7
16.8
—
9
9
(3021879) Hepatitis B virus core Ab [Presence] in Serum
17
52
3.75
5.02
1.2
1.7
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
15
42
4.04
4.99
6.7
2.9
u/ml
50.7
3542.9
0.54
15
36
(3030905) Polymorphonuclear cells [#/volume] in Blood
9
10
9.76
4.90
2.2
2.3
e9/l
4.8
4.1
—
9
10
(3035350) Ketones [Presence] in Urine by Test strip
62
391
2.59
4.89
6.1
3.8
estimate
0.0
0.0
0.00
15
71
(3021601) Nitrite [Presence] in Urine by Test strip
62
392
2.58
4.85
8.4
5.2
estimate
0.0
0.0
0.00
14
70
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
12
29
4.58
4.78
1.4
1.2
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
44
240
2.51
4.68
4.6
3.8
mg/mmol
19.9
9.4
0.55
29
145
(3016650) Hepatitis A virus Ab [Presence] in Serum
9
11
8.87
4.67
1.0
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
12
30
4.42
4.58
1.4
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
12
30
4.42
4.58
1.4
1.2
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
62
399
2.51
4.56
6.2
3.8
estimate
0.0
0.0
0.00
15
67
(3019550) Sodium [Moles/volume] in Serum or Plasma
98
870
+∞
4.55
69.3
15.9
mmol/l
138.1
139.7
5.58
98
848
(3007164) IgA [Mass/volume] in Serum or Plasma
35
174
2.57
4.49
1.8
1.3
g/l
3.3
2.6
0.44
18
102
(3044941) Cell count panel - Synovial fluid
9
12
8.12
4.46
2.6
1.6
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
28
125
2.74
4.43
1.6
1.7
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
92
762
4.38
4.37
7.6
4.5
mu/l
2.0
2.0
0.03
82
682
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
8
9
9.55
4.36
1.0
1.0
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
16
52
3.48
4.31
12.2
8.4
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
81
602
2.99
4.29
6.4
4.0
pmol/l
15.2
14.8
0.44
75
539
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
9
13
7.49
4.27
2.2
1.6
nmol/l
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
13
37
3.90
4.21
6.2
4.7
mmol/l
27.1
24.6
1.28
13
37
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
32
157
2.54
4.18
2.2
1.7
pmol/l
475.7
475.1
0.00
25
130
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
9
14
6.95
4.08
3.8
2.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
42
236
2.36
4.07
1.3
1.4
—
—
—
0
0
(3020891) Body temperature
12
33
4.00
4.06
10.8
4.6
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
6
5
12.65
3.81
1.0
1.0
g/l
1.6
1.5
—
6
5
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
8
12
7.14
3.75
1.0
1.3
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
52
329
2.24
3.73
6.9
3.6
ng/l
65.6
42.1
0.27
43
229
(3011397) Hemoglobin [Presence] in Urine by Test strip
36
197
2.31
3.64
3.8
3.6
—
—
—
0
0
(3011648) Oxygen content in Venous blood
7
9
8.27
3.62
1.0
1.4
%
11.7
11.1
—
7
9
(3018405) Lactate [Moles/volume] in Arterial blood
12
36
3.66
3.61
7.4
5.5
mmol/l
1.7
1.5
0.26
12
36
(40768806) Pleura Pathology biopsy report
6
6
10.54
3.54
1.3
2.7
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
6
6
10.54
3.54
1.2
1.5
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
98
892
+∞
3.52
65.9
16.5
umol/l
78.3
78.0
0.04
98
892
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
12
37
3.56
3.47
5.0
1.5
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
39
226
2.21
3.41
3.7
3.2
mg/l
106.2
56.5
0.57
30
143
(3017181) Myelocytes/100 leukocytes in Blood
19
79
2.74
3.39
4.2
3.5
%
2.2
1.1
0.54
11
25
(3022145) Colonoscopy Study observation
22
99
2.58
3.37
1.5
1.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
24
114
2.46
3.29
1.8
1.4
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
13
44
3.25
3.27
3.2
2.4
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
9
20
4.84
3.20
1.9
1.2
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
17
69
2.77
3.16
4.3
3.8
%
0.4
0.4
—
9
19
(3019060) Gas panel - Arterial blood
16
63
2.84
3.14
7.1
4.9
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
7
12
6.18
3.08
4.0
2.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
5
5
10.43
3.01
1.0
1.0
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
5
5
10.43
3.01
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
5
5
10.43
3.01
1.0
1.0
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
5
5
10.43
3.01
1.6
4.2
nmol/l
68.2
66.0
—
5
5
(3022313) Gas panel - Capillary blood
10
30
3.60
2.99
8.3
4.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
89
755
2.94
2.94
56.8
15.1
%
36.0
40.0
4.53
60
554
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
7
13
5.70
2.92
1.3
1.6
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
6
9
7.01
2.91
1.0
1.3
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
12
42
3.12
2.86
1.5
1.3
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
9
23
4.20
2.85
1.1
2.2
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
9
23
4.20
2.85
1.2
1.2
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
91
788
3.17
2.82
55.1
13.1
ml/min/173m2
82.2
80.9
0.19
82
624
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
73
564
2.15
2.78
7.2
2.9
u/l
128.2
45.9
1.99
66
526
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
9
24
4.02
2.75
2.1
2.0
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
8
19
4.49
2.74
1.1
1.1
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
6
10
6.31
2.74
1.2
1.1
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
16
68
2.62
2.73
3.7
3.8
%
1.0
0.5
—
8
14
(3021788) Differential panel - Synovial fluid
7
15
4.94
2.65
1.7
1.5
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
8
20
4.26
2.63
1.3
1.2
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
32
189
2.03
2.56
1.5
1.2
u/ml
1.0
1.4
—
6
43
(44816559) Phosphatidylethanol [Mass/volume] in Blood
8
21
4.05
2.52
1.1
1.0
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
8
21
4.05
2.52
3.0
1.4
%
87.3
90.9
—
8
21
(40760892) CBC W Ordered Manual Differential panel - Blood
31
182
2.03
2.52
4.9
5.8
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
26
144
2.10
2.46
1.4
1.2
iu/ml
46.4
24.2
—
8
48
(3044889) 12 lead EKG panel
77
621
2.12
2.42
6.6
3.7
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
14
60
2.56
2.34
7.4
3.3
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
8
23
3.69
2.32
3.1
1.5
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
8
23
3.69
2.32
1.4
2.0
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
6
13
4.84
2.31
1.0
1.3
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
7
18
4.10
2.30
1.3
1.1
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
9
29
3.31
2.29
1.6
2.7
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
5
9
5.78
2.24
1.2
1.1
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
5
9
5.78
2.24
1.4
1.8
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
5
9
5.78
2.24
1.0
1.4
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
5
9
5.78
2.24
1.0
1.4
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
38
249
1.86
2.20
3.8
2.8
umol/l
336.2
8598.6
1.53
32
213
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
7
19
3.88
2.19
3.6
1.6
%
182.0
189.3
—
7
19
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
7
19
3.88
2.19
3.4
1.6
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
6
14
4.49
2.18
1.2
1.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
6
14
4.49
2.18
3.7
1.6
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
7
20
3.68
2.10
3.1
3.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
7
21
3.51
2.00
1.1
1.5
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
6
16
3.92
1.96
1.2
2.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
6
16
3.92
1.96
1.0
1.5
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
82
698
2.07
1.92
67.5
17.9
%
14.8
13.7
5.05
82
689
(3049717) Cytology report of Urine Cyto stain
7
22
3.34
1.92
2.1
2.0
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
6
17
3.69
1.87
1.0
1.5
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
14
67
2.27
1.86
4.7
3.7
%
0.0
0.1
—
7
17
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
5
12
4.33
1.84
1.2
1.2
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
7
23
3.20
1.83
1.6
1.4
—
—
—
0
0
(40768443) Skin Pathology biopsy report
9
36
2.65
1.79
1.2
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
6
18
3.48
1.77
1.0
1.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
6
18
3.48
1.77
1.0
1.4
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
6
18
3.48
1.77
1.0
1.4
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
98
934
+∞
1.76
76.6
20.8
g/l
118.7
136.7
19.59
98
919
(3035941) MCH [Entitic mass]
98
933
+∞
1.76
75.8
20.7
pg
30.6
30.4
0.56
98
919
(3026361) Erythrocytes [#/volume] in Blood
98
933
+∞
1.76
76.1
20.7
e12/l
3.9
4.5
16.60
98
902
(3010813) Leukocytes [#/volume] in Blood
98
933
+∞
1.76
76.1
20.8
e9/l
7.3
6.5
3.56
98
903
(3024731) MCV [Entitic volume]
98
933
+∞
1.76
75.8
20.7
fl
92.5
91.1
1.70
98
919
(3007461) Platelets [#/volume] in Blood
98
932
+∞
1.75
76.2
20.8
e9/l
255.3
245.2
0.67
98
905
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
7
26
2.82
1.61
1.6
1.6
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
0
44
0.00
1.56
0.0
1.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
19
299
0.55
1.54
3.6
2.8
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
9
37
2.57
1.52
5.2
3.5
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
5
16
3.23
1.45
1.2
1.9
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
5
16
3.23
1.45
1.0
2.9
—
—
—
0
0
(3002256) Pathology report gross observation
18
105
1.88
1.45
1.2
1.3
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
31
214
1.66
1.43
7.8
3.4
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
5
17
3.04
1.37
1.0
1.2
—
—
—
0
0
(3013512) EKG study
34
243
1.61
1.36
6.6
3.9
—
—
—
0
0
(3019225) pH of Specimen
14
77
1.95
1.33
9.1
4.4
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
18
2.87
1.30
1.4
1.8
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
5
20
2.58
1.16
1.4
1.7
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
8
41
2.03
1.11
11.0
3.0
e6/l
0.2
0.1
—
8
41
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
39
300
1.50
1.10
7.4
3.9
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
6
27
2.30
0.95
1.2
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
10
56
1.88
0.91
5.2
2.1
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
86
794
1.68
0.88
7.5
5.4
mmol/mol
40.9
39.5
0.54
77
729
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
0
25
0.00
0.80
0.0
1.6
—
—
—
0
0
(40768793) Breast Pathology biopsy report
0
26
0.00
0.79
0.0
1.2
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
7
38
1.91
0.75
1.0
1.0
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
26
1.97
0.71
1.6
1.1
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
27
209
1.40
0.71
8.4
3.8
estimate
0.0
0.0
0.00
13
67
(3008898) HLA-B27 [Presence]
6
35
1.76
0.59
1.5
1.1
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
17
213
0.76
0.42
2.5
2.8
ug/l
0.4
0.8
3.98
12
139
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
1.4
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
0
17
0.00
0.41
0.0
1.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
9
71
1.29
0.37
1.1
1.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
6
45
1.35
0.34
1.3
1.6
—
—
—
0
0
(40761535) Cells panel - Urine sediment
8
63
1.29
0.28
3.8
3.6
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
14
114
1.27
0.27
18.1
7.8
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
9
75
1.22
0.26
1.2
1.8
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
25
282
0.85
0.24
3.7
4.3
%
18.5
23.0
—
9
132
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
84
864
0.81
0.23
5.4
5.1
mmol/l
2.2
2.8
6.16
74
788
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
2.7
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(4146454)
0
10
0.00
0.21
0.0
2.6
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
6
47
1.29
0.21
1.7
1.1
u/ml
117.3
205.8
—
6
42
(3000492) Spirometry study
10
81
1.26
0.19
1.3
1.5
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
85
827
1.21
0.19
5.6
4.6
mmol/l
6.2
5.9
1.01
78
753
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
83
851
0.84
0.18
5.0
4.7
mmol/l
4.2
4.7
4.00
73
782
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
51
483
1.12
0.17
3.3
2.8
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
9
80
1.14
0.15
1.8
2.0
nmol/l
14.0
15.5
—
9
73
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
83
847
0.87
0.13
5.0
4.6
mmol/l
1.3
1.5
1.91
73
773
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
33
350
0.91
0.11
3.5
4.5
ug/l
1.6
1.9
0.51
28
309
(3013139) Helicobacter pylori Ag [Presence] in Stool
5
47
1.07
0.09
2.4
1.1
—
—
—
0
0
(4010399)
6
58
1.04
0.08
1.0
1.4
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
82
830
0.93
0.04
4.9
4.1
mmol/l
1.6
1.3
1.40
71
755
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
11
101
1.10
0.04
1.6
1.3
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
12
112
1.08
0.03
2.0
1.3
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
8
0.00
0.00
0.0
2.6
—
14.0
—
0
8
(4268621)
0
9
0.00
0.00
0.0
1.9
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
8.8
—
1331.5
—
0
8
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
12.5
—
2448.9
—
0
8
(4027681)
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.9
—
3.5
—
0
8
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
0
5
0.00
0.00
0.0
2.4
—
8.0
—
0
5
(3051593) INR in Capillary blood by Coagulation assay
0
5
0.00
0.00
0.0
4.6
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
6
63
0.95
0.00
1.8
1.8
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
0
5
0.00
0.00
0.0
2.4
—
3.7
—
0
5
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
7
0.00
0.00
0.0
1.1
—
9.3
—
0
7
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
301.5
—
0
5
(40768441) Liver Pathology biopsy report
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint E4_MG_DEF and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have E4_MG_DEF.

N-year risk Females Males
1 No data No data
5 No data No data
10 No data No data
15 No data No data
20 No data No data

Relationships between endpoints

↥

Index endpoint: E4_MG_DEF – Magnesium deficiency

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data